[{"id":"bc495e67-74a7-4a72-bd22-a1860b6ee0e1","acronym":"","url":"https://clinicaltrials.gov/study/NCT03030417","created_at":"2021-01-29T07:14:03.543Z","updated_at":"2024-07-02T16:35:32.645Z","phase":"Phase 1","brief_title":"Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas","source_id_and_acronym":"NCT03030417","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LMP744"],"overall_status":"Completed","enrollment":" Enrollment 36","initiation":"Initiation: 02/27/2017","start_date":" 02/27/2017","primary_txt":" Primary completion: 10/02/2023","primary_completion_date":" 10/02/2023","study_txt":" Completion: 10/12/2023","study_completion_date":" 10/12/2023","last_update_posted":"2023-10-19"}]